Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...

Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is ...

Pfizer CEO Albert Bourla said he had spoken to Robert F. Kennedy Jr. in an effort to “find opportunities on things we can ...

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell, swollen lymph ...

The lawsuit filed Thursday in Marion County Superior Court accuses Mylan and Pfizer of conspiring to raise the price of ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

Attorney General Todd Rokita has filed a lawsuit alleging that Mylan and Pfizer have conspired to increase EpiPen’s price by ...

Indiana Attorney General Todd Rokita is suing two pharmaceutical companies over alleged anticompetitive acts regarding a life ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in oncology and obesity.

The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...